EFFECTIVENESS AND SAFETY OF VELAGLUCERASE ALFA IN TREATMENT OF GAUCHER DISEASE TYPE 1 (ACCORDING TO INTERNATIONAL STUDIES)

The article is dedicated to modern approaches to treatment of Gaucher's disease. The authors list the primary aspects of the disease and present data on the origin and introduction of pathogenetic enzyme replacement therapy to clinical practice. Review of international clinical studies demonstr...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: O. S. Gundobina (Συγγραφέας), G. B. Movsisyan (Συγγραφέας), E. V. Komarova (Συγγραφέας), L. S. Namazova-Baranova (Συγγραφέας)
Μορφή: Βιβλίο
Έκδοση: Union of pediatricians of Russia, 2014-11-01T00:00:00Z.
Θέματα:
Διαθέσιμο Online:Connect to this object online.
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1d41a926b6ae4c4fbb45279bccaa463f
042 |a dc 
100 1 0 |a O. S. Gundobina  |e author 
700 1 0 |a G. B. Movsisyan  |e author 
700 1 0 |a E. V. Komarova  |e author 
700 1 0 |a L. S. Namazova-Baranova  |e author 
245 0 0 |a EFFECTIVENESS AND SAFETY OF VELAGLUCERASE ALFA IN TREATMENT OF GAUCHER DISEASE TYPE 1 (ACCORDING TO INTERNATIONAL STUDIES) 
260 |b Union of pediatricians of Russia,   |c 2014-11-01T00:00:00Z. 
500 |a 1727-5776 
500 |a 2500-3089 
500 |a 10.15690/pf.v11i6.1215 
520 |a The article is dedicated to modern approaches to treatment of Gaucher's disease. The authors list the primary aspects of the disease and present data on the origin and introduction of pathogenetic enzyme replacement therapy to clinical practice. Review of international clinical studies demonstrates high effectiveness and safety of long-term enzyme replacement therapy with velaglucerase alfa in patients with confirmed type I Gaucher's disease. 
546 |a RU 
690 |a gaucher's disease 
690 |a enzyme replacement therapy 
690 |a velaglucerase alfa 
690 |a children 
690 |a Pediatrics 
690 |a RJ1-570 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Педиатрическая фармакология, Vol 11, Iss 6, Pp 52-55 (2014) 
787 0 |n https://www.pedpharma.ru/jour/article/view/35 
787 0 |n https://doaj.org/toc/1727-5776 
787 0 |n https://doaj.org/toc/2500-3089 
856 4 1 |u https://doaj.org/article/1d41a926b6ae4c4fbb45279bccaa463f  |z Connect to this object online.